PRPF31 anticorps (C-Term)
Aperçu rapide pour PRPF31 anticorps (C-Term) (ABIN7469537)
Antigène
Voir toutes PRPF31 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human PRPF31. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: NT2D1
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- PRPF31 (Pre-mRNA Processing Factor 31 (PRPF31))
-
Autre désignation
- PRPF31
-
Sujet
-
Synonyms: pre-mRNA processing factor 31 , NY-BR-99 , PRP31 , RP11 , SNRNP61
Background: This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.
-
Poids moléculaire
- 55 kDa
-
ID gène
- 26121
-
UniProt
- Q8WWY3
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Antigène
-